734-936-8000 - Service Desk | Request Support

Clinical Updates for Treating Patients with Opioid Use Disorder

To begin this activity, click Enroll. Once logged in, learners can access educational content, assessments, and evaluations. Learners who successfully complete the activity will be able to print a certificate.

Step Status
Educational Materials
Release Date: Sat, 1/1/22
Termination Date: Tue, 4/30/24
Credits: 0.75
Description: There are no relevant financial relationships to disclose for this activity.

Educational Planner: Nijuanna Irby-Johnson, MD
Co-Planner: Lindsay Lindsay Quade, MD
Presenter: Pooja Lagisetty, MD
Activity Coordinator: Cheri Breadon
Educational Objectives: At the end of this activity, participant should be able to:
  1. Know when to treat with medications
  2. Know what medications are available and how to start them
  3. Know which treatment is right for low severity
  4. Practice Transformation Incentives
  5. Use Resources that are available thru University of Michigan
Target Audience: This activity is appropriate for Nurse Practitioners, Nurses, Physician Assistants, Physicians in the fields of General Medicine, Internal Medicine.
Accreditation and Credit Designation:

The University of Michigan Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Michigan Medical School designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Released: April 2021
Terminates: April 2024
Additional Info:

Bibliographic Resources

  1. Lagisetty P, Klasa K, Bush C, Heisler M, Chopra V, Bohnert A. Primary care models for treating opioid use disorders: What actually works? A systematic review. PLoS One. 2017;12(10). doi:10.1371/journal.pone.0186315
  2. Duncan A, Anderman J, Deseran T, Reynolds I, Stein BD. Monthly Patient Volumes of Buprenorphine-Waivered Clinicians in the US. JAMA Netw Open. 2020;3(8):e2014045. doi:10.1001/jamanetworkopen.2020.14045
  3. Lagisetty PA, Ross R, Bohnert A, Clay M, Maust DT. Buprenorphine Treatment Divide by Race/Ethnicity and Payment. JAMA Psychiatry. 2019;76(9):979-981. doi:10.1001/jamapsychiatry.2019.0876
Category: Pain and Symptom Management

Credits available:

AMA PRA Category 1: 0.75
Participation: 0.75